| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.33 | 9e-25 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.32 | 3e-20 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.28 | 8e-16 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-15 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.27 | 9e-15 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-11 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-10 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.32 | 1e-09 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.27 | 2e-09 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-09 |